← Leaderboards
Elinore F. McCance-Katz
Yale University
$13,032,111
Attributed
$13,402,129
Total exposure
21
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–11$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$13,402,129 · 21
By mechanism
R01$8,764,342 · 5
M01$2,454,575 · 12
K24$917,562 · 1
K02$639,104 · 1
P01$555,027 · 1
R29$71,519 · 1
Top collaborators
- Stephen S. Dominy3 shared
- Joseph M Mccune3 shared
Most similar at Yale University
Same institution · by research overlap
- Vasilis Vasiliou$20,612,734
- Richard S Schottenfeld$12,878,104
- Silvia Vilarinho$2,741,114
- Robert T Malison$17,226,399
- Gerald Friedland$34,535
Others in their field
Top investigators on “Drug Interactions”
- Sharon A Nachman · Johns Hopkins University$209,857,565
- David Heimbrook · Leidos Biomedical Research, Inc.$173,156,929
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Ralph Parchment · Leidos Biomedical Research, Inc.$140,676,376
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
Research focus
Drug InteractionsBuprenorphineHuman SubjectClinical ResearchMethadoneHiv InfectionsHuman Therapy EvaluationDrug Abuse ChemotherapyProtease InhibitorPharmaceutical PreparationsParticipantRitonavirPharmacokineticsOpiate AlkaloidOpioidAntiretroviral TherapyToxic EffectAntiaids AgentAnti-Retroviral AgentsCocainePatient Oriented ResearchResearch DesignFundingClinical Trials
Grant awards (57)
Role of Buprenorphine in Improving Clinical Care in Opioid Addiction and HIV$185,550
K24 · FY2011 · DA · contact PI
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection$151,549
R01 · FY2011 · AA · contact PI
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection$449,451
R01 · FY2010 · AA · contact PI
Disulfiram Interactions With HIV Medications: Clinical Implications$428,339
R01 · FY2010 · DA · contact PI
Role of Buprenorphine in Improving Clinical Care in Opioid Addiction and HIV$184,551
K24 · FY2010 · DA · contact PI
Model for the Evaluation of the Immunomodulatory Effects of Opioid Addiction, Wit$156,378
P01 · FY2010 · DA
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection$444,405
R01 · FY2009 · AA · contact PI
Disulfiram Interactions With HIV Medications: Clinical Implications$416,490
R01 · FY2009 · DA · contact PI
Model for the Evaluation of the Immunomodulatory Effects of Opioid Addiction, Wit$248,524
P01 · FY2009 · DA
Role of Buprenorphine in Improving Clinical Care in Opioid Addiction and HIV$183,579
K24 · FY2009 · DA · contact PI
Opioids & HIV Medications: Interactions in Drug Abusers$609,990
R01 · FY2008 · DA · contact PI
Disulfiram Interactions With HIV Medications: Clinical Implications$551,992
R01 · FY2008 · DA · contact PI
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection$437,882
R01 · FY2008 · AA · contact PI
INTERACTION OF HIV MEDICATIONS WITH OPIATE THERAPY MEDICATIONS$252,109
M01 · FY2008 · RR · contact PI
Role of Buprenorphine in Improving Clinical Care in Opioid Addiction and HIV$182,161
K24 · FY2008 · DA · contact PI
Model for the Evaluation of the Immunomodulatory Effects of Opioid Addiction, Wit$150,125
P01 · FY2008 · DA
INTERACTION OF HIV MEDICATIONS WITH OPIATE THERAPY MEDICATIONS$866,146
M01 · FY2007 · RR · contact PI
Opioids & HIV Medications: Interactions in Drug Abusers$596,602
R01 · FY2007 · DA · contact PI
Role of Buprenorphine in Improving Clinical Care in Opioid Addiction and HIV$181,721
K24 · FY2007 · DA · contact PI
Opioids & HIV Medications: Interactions in Drug Abusers$602,002
R01 · FY2006 · DA · contact PI
INTERACTION OF HIV MEDICATIONS WITH OPIATE THERAPY MEDICATIONS$474,705
M01 · FY2006 · RR · contact PI
Opioids & HIV Medications: Interactions in Drug Abusers$127,940
R01 · FY2006 · DA · contact PI
INTERACTION OF HIV MEDICATIONS WITH OPIATE THERAPY MEDICATIONS$10,501
M01 · FY2006 · RR · contact PI
THE EFFECT OF COCAETHYLENE ON RESPONSES TO COCAINE$2,846
M01 · FY2006 · RR · contact PI
INTRAVENOUS COCAINE ADMINISTRATION IN THE PRESENCE OF DISULFIRAM IN HUMANS: PHAR$316
M01 · FY2006 · RR · contact PI
Opioids &HIV Medications: Interactions in Drug Abusers$533,998
R01 · FY2005 · DA
INTERACTION OF HIV MEDICATIONS WITH OPIATE THERAPY MEDICATIONS$461,825
M01 · FY2005 · RR
Enhancing Health Care of Drug Users with HIV$127,211
K02 · FY2005 · DA
THE EFFECT OF COCAETHYLENE ON RESPONSES TO COCAINE$63,130
M01 · FY2005 · RR
INTRAVENOUS COCAINE ADMINISTRATION IN THE PRESENCE OF DISULFIRAM IN HUMANS$45,305
M01 · FY2005 · RR
Opioids &HIV Medications: Interactions in Drug Abusers$561,735
R01 · FY2004 · DA
INTERACTION OF HIV MEDICATIONS WITH OPIATE THERAPY MEDS.$142,633
M01 · FY2004 · RR
Enhancing Health Care of Drug Users with HIV$127,158
K02 · FY2004 · DA
Intravenous Cocaine Admin. in the Presence of Disulfiram$25,163
M01 · FY2004 · RR
The Effect of Cocaethylene on Responses to Cocaine$6,291
M01 · FY2004 · RR
OPIOIDS AND HIV MEDICATIONS--INTERACTIONS IN DRUG ABUSER$468,926
R01 · FY2003 · DA
Enhancing Health Care of Drug Users with HIV$128,834
K02 · FY2003 · DA
COCAETHYLENE COCAINE AGONIST THERAPY/TOLERANCE INDUCTION$331,076
R01 · FY2002 · DA
OPIOIDS AND HIV MEDICATIONS--INTERACTIONS IN DRUG ABUSER$248,452
R01 · FY2002 · DA
OPIOIDS AND HIV MEDICATIONS--INTERACTIONS IN DRUG ABUSER$207,000
R01 · FY2002 · DA
COCAINE, ALCOHOL, AND COCAETHYLENE--CLINICAL EFFECTS$108,013
R01 · FY2002 · DA
Enhancing Health Care of Drug Users with HIV$86,400
K02 · FY2002 · DA
OPIOIDS AND HIV MEDICATIONS--INTERACTIONS IN DRUG ABUSER$63,097
R01 · FY2002 · DA
Enhancing Health Care of Drug Users with HIV$41,575
K02 · FY2002 · DA
COCAINE, ALCOHOL, AND COCAETHYLENE--CLINICAL EFFECTS$34,556
R01 · FY2002 · DA
COCAETHYLENE COCAINE AGONIST THERAPY/TOLERANCE INDUCTION$7,536
R01 · FY2002 · DA
OPIOIDS AND HIV MEDICATIONS--INTERACTIONS IN DRUG ABUSER$381,456
R01 · FY2001 · DA
COCAETHYLENE COCAINE AGONIST THERAPY/TOLERANCE INDUCTION$356,751
R01 · FY2001 · DA
Enhancing Health Care of Drug Users with HIV$127,926
K02 · FY2001 · DA
COCAINE, ALCOHOL, AND COCAETHYLENE--CLINICAL EFFECTS$105,925
R01 · FY2001 · DA
NELFINAVIR EFFECTS ON OPIOID DISPOSITION$0
M01 · FY2001 · RR
OPIATE DEPENDENCE PHARMACOTHERAPY MAINTENANCE EFFECTS ON ZIDOVUDINE (AZT)$0
M01 · FY2001 · RR
OPIOIDS AND HIV MEDICATIONS--INTERACTIONS IN DRUG ABUSER$539,179
R01 · FY2000 · DA
COCAINE, ALCOHOL, AND COCAETHYLENE--CLINICAL EFFECTS$71,519
R29 · FY2000 · DA
OPIATE DEPENDENCE PHARMACOTHERAPY MAINTENANCE EFFECTS ON ZIDOVUDINE (AZT)$34,535
M01 · FY2000 · RR
NELFINAVIR EFFECTS ON OPIOID DISPOSITION$34,535
M01 · FY2000 · RR
PHARMACOKINETICS OF COCAETHYLENE$34,535
M01 · FY2000 · RR